Citation Impact
Citing Papers
Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: A meta-analysis of randomized, placebo-controlled trials*
2006
Bacteremia Associated With Toothbrushing and Dental Extraction
2008 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Salt or no salt in the treatment of cirrhotic ascites: a randomised study.
1986
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
UK guidelines on the management of variceal haemorrhage in cirrhotic patients
2015
Abdominal decompression plays a major role in early postparacentesis haemodynamic changes in cirrhotic patients with tense ascites
2001
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Increased intestinal permeability as a predictor of bacterial infections in patients with decompensated liver cirrhosis and hemorrhage
2010
Reductions in 28-Day Mortality Following Hospital Admission for Upper Gastrointestinal Hemorrhage
2011 Standout
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Effect of Intravenous Albumin on Renal Impairment and Mortality in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis
1999
Geriatric Nutritional Risk Index: a new index for evaluating at-risk elderly medical patients
2005 Standout
“Rescue” regimens after Helicobacter pylori treatment failure
2008
Hepatocellular carcinoma
2003 Standout
A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts
2000 Standout
Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage
1992
Antibiotic resistance and CYP2C19 polymorphisms affect the efficacy of concomitant therapies forHelicobacter pyloriinfection: an open-label, randomized, single-centre clinical trial
2016
Incidence and Predictive Factors of First Episode of Spontaneous Bacterial Peritonitis in Cirrhosis With Ascites: Relevance of Ascitic Fluid Protein Concentration
1992
Liver fibrosis
2005 Standout
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Impaired Function of Macrophage Fcγ Receptors and Bacterial Infection in Alcoholic Cirrhosis
1994
Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: A cross-over study
2011
Effects of anti-Helicobacter pylori concomitant therapy and probiotic supplementation on the throat and gut microbiota in humans
2017
A Model to Predict Survival in Patients With End–Stage Liver Disease
2001 Standout
Clinical trial: levofloxacin‐based quadruple therapy was inferior to traditional quadruple therapy in the treatment of resistant Helicobacter pylori infection
2007
Management of adult patients with ascites due to cirrhosis†
2004
Bismuth-Based Quadruple Therapy Using a Single Capsule of Bismuth Biskalcitrate, Metronidazole, and Tetracycline Given With Omeprazole Versus Omeprazole, Amoxicillin, and Clarithromycin for Eradication of Helicobacter pylori in Duodenal Ulcer Patients: a Prospective, Randomized, Multicenter, North American Trial
2003
Epidemiology of Severe Hospital‐Acquired Infections in Patients with Liver Cirrhosis: Effect of Long‐Term Administration of Norfloxacin
1998
Intestinal permeability and complications in liver cirrhosis: A prospective cohort study
2012
Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: Results of a double-blind, placebo-controlled trial
1990
Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites
1993
Sequential Therapy for Helicobacter pylori Eradication
2010
Antibiotic treatment for Helicobacter pylori : Is the end coming?
2015
Effects of a selective vasopressin V2 receptor antagonist, satavaptan, on ascites recurrence after paracentesis in patients with cirrhosis
2010
Probiotics inHelicobacter pylorieradication therapy: A systematic review and meta-analysis
2015
Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy
2016
Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis
1988 Standout
Small Intestine Dysmotility and Bacterial Overgrowth in Cirrhotic Patients With Spontaneous Bacterial Peritonitis
1998
Norfloxacin vs Ceftriaxone in the Prophylaxis of Infections in Patients With Advanced Cirrhosis and Hemorrhage
2006
Prognostic significance of bacterial infection in bleeding cirrhotic patients: A prospective study
1995
Proton pump inhibitors: an update of their clinical use and pharmacokinetics
2008
Deficient phospholipase C activity in blood polimorphonuclear neutrophils from patients with liver cirrhosis
2004
Third-Line Rescue Therapy with Bismuth-Containing Quadruple Regimen After Failure of Two Treatments (with Clarithromycin and Levofloxacin) for H. pylori Infection
2013
Primary Prophylaxis of Spontaneous Bacterial Peritonitis Delays Hepatorenal Syndrome and Improves Survival in Cirrhosis
2007
Treatment of Helicobacter pylori
2007
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
The Physiologic Basis of Diuretic Synergism: Its Role in Treating Diuretic Resistance
1991
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Efficacy and safety of the stepped care medical treatment of ascites in liver cirrhosis: a randomized controlled clinical trial comparing two diets with different sodium content
1993
Oral Antibiotic Prophylaxis Reduces Spontaneous Bacterial Peritonitis Occurrence and Improves Short-Term Survival in Cirrhosis: A Meta-Analysis
2009
Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial*1
1995
Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: A pilot study
2002
Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta‐analysis
2005
The stomach in health and disease
2015
Selective intestinal decontamination prevents spontaneous bacterial peritonitis
1991
Helicobacter pylori Eradication Therapy Success Regarding Different Treatment Period Based on Clarithromycin or Metronidazole Triple‐Therapy Regimens
2009
Vascular disorders of the liver # †
2008 Standout
Significance of Serum Pepsinogens as a Biomarker for Gastric Cancer and Atrophic Gastritis Screening: A Systematic Review and Meta-Analysis
2015
Pathological bacterial translocation in liver cirrhosis
2013
Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis†
1996
Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis
1988
Spontaneous Bacterial Peritonitis: An Update
1995
Transjugular intrahepatic portosystemic shunt in patients with end-stage liver disease: Results in 85 patients
1996
Management of Hepatocellular Carcinoma *
2005 Standout
Prevalence and prognostic value of hepatocellular carcinoma in cirrhotic patients presenting with spontaneous bacterial peritonitis
2000
Advantages of the new loop diuretic torasemide over furosemide in patients with cirrhosis and ascites
1993
Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis
2010
ORAL MICROFLORA AS A CAUSE OF ENDOCARDITIS AND OTHER DISTANT SITE INFECTIONS
1999
The Management of Ascites in Cirrhosis: Report on the Consensus Conference of the International Ascites Club
2003
Portal hypertensive bleeding in cirrhosis
2016 Standout
Recurrence of spontaneous bacterial peritonitis in cirrhosis: Frequency and predictive factors
1988
Levofloxacin-based triple therapy for Helicobacter pylori re-treatment: Role of bacterial resistance
2007
Management of Cirrhosis and Ascites
2004
Deleterious Effects of Beta-Blockers on Survival in Patients With Cirrhosis and Refractory Ascites†,‡
2010
Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety
2003
Helicobacter pylori treatment in the era of increasing antibiotic resistance
2010
Altered intestinal function precedes the appearance of bacterial DNA in serum and ascites in patients with cirrhosis: a pilot study
2010
RISK FACTORS OF INVASIVE CANDIDA AND NON-CANDIDA FUNGAL INFECTIONS AFTER LIVER TRANSPLANTATION1
1996
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy
2013
Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori
2011
Randomized Clinical Trial: Esomeprazole, Bismuth, Levofloxacin, and Amoxicillin or Cefuroxime as First-Line Eradication Regimens for Helicobacter pylori Infection
2017
Repeated paracentesis and i.v. albumin infusion to treat ‘tense’ ascites in cirrhotic patients
1987
Polymorphonuclear cell count response and duration of antibiotic therapy in spontaneous bacterial peritonitis†
1989
The “Golden Age” of Probiotics: A Systematic Review and Meta-Analysis of Randomized and Observational Studies in Preterm Infants
2017 Standout
The North American Study for the Treatment of Refractory Ascites
2003
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions
2018 Standout
Management of adult patients with ascites caused by cirrhosis†
1998
Gut flora in health and disease
2003 Standout
Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis
1988
Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area
2016
Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites
1995
Systematic review and meta-analysis: susceptibility-guided versus empirical antibiotic treatment forHelicobacter pyloriinfection
2015
Reviews: The Role of Albumin in Human Physiology and Pathophysiology, Part III: Albumin and Disease States
1991
Empiric Quadruple vs. Triple Therapy for Primary Treatment of Helicobacter pylori Infection: Systematic Review and Meta-Analysis of Efficacy and Tolerability
2009
Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial
2009
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
2008 Standout
Meta‐analysis: the efficacy, adverse events, and adherence related to first‐line anti‐Helicobacter pylori quadruple therapies
2004
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
2013 Standout
UK guidelines on the management of variceal haemorrhage in cirrhotic patients
2000
Gastric cancer
2020 Standout
Clinical evaluation of four one-week triple therapy regimens in eradicatingHelicobacter pyloriinfection
2004
Albumin infusion in patients undergoing large-volume paracentesis: A meta-analysis of randomized trials
2011
Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document
2000 Standout
Meta-analysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding - an updated Cochrane review
2011
Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites
1988
Optimizing clarithromycin-containing therapy forHelicobacter pyloriin the era of antibiotic resistance
2014
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
2014 Standout
Formation and Immunological Properties of Aldehyde-derived Protein Adducts following Alcohol Consumption
2008
A review of rescue regimens after clarithromycin-containing triple therapy failure (forHelicobacter pylorieradication)
2013
Systemic Antibiotic Prophylaxis After Gastrointestinal Hemorrhage in Cirrhotic Patients With A High Risk of Infection
1996
Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites
1993
Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori
2012
Third‐line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures
2006
Should bleeding tendency deter abdominal paracentesis?
2005
Empirical rescue therapy after Helicobacter pylori treatment failure: a 10‐year single‐centre study of 500 patients
2007
Continuous Versus Inpatient Prophylaxis of the First Episode of Spontaneous Bacterial Peritonitis With Norfloxacin
1997
Infection in Solid-Organ Transplant Recipients
2007 Standout
Effects of oral ciprofloxacin on aerobic gram-negative fecal flora in patients with cirrhosis: results of short- and long-term administration, with daily and weekly dosages
1998
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Efficacy of 1st-line bismuth-containing quadruple therapies with levofloxacin or clarithromycin for the eradication of Helicobacter pylori infection
2017
Diuretic requirements after therapeutic paracentesis in non-azotemic patients with cirrhosis. A randomized double-blind trials of spironolactone versus placebo
1997
A prospective study of bacterial infections in patients with cirrhosis
1993
Meta‐analysis: high‐dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradication
2008
Management of patients with nonvariceal upper gastrointestinal hemorrhage before and after the adoption of the Rockall score, in the Italian Gastroenterology Units
2007
Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis
2002
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
2006 Standout
Role of intestinal bacterial overgrowth and intestinal motility in bacterial translocation in experimental cirrhosis
2005
Splanchnic sympathectomy prevents translocation and spreading of E coli but not S aureus in liver cirrhosis
2010
Randomized Trial Comparing Albumin and Saline in the Prevention of Paracentesis–Induced Circulatory Dysfunction in Cirrhotic Patients With Ascites
2003
Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination
1997
Infection in Organ-Transplant Recipients
1998 Standout
Analysis of clinical course and prognosis of culture-positive spontaneous bacterial peritonitis and neutrocytic ascites
1992
The pros, cons, and many unknowns of probiotics
2019 Standout
The Effect of Ciprofloxacin in the Prevention of Bacterial Infection in Patients With Cirrhosis After Upper Gastrointestinal Bleeding
1998
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Infectious disease complications of Gl endoscopy: Part I, endogenous infections
2003
Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management
2003
Transarterial embolization for hepatocellular carcinoma. Antibiotic prophylaxis and clinical meaning of postembolization fever
1995
Bacterial translocation (BT) in cirrhosis†
2005
Myocarditis
2009 Standout
Liver transplantation in hyponatremic patients with emphasis on central pontine myelinolysis
1998
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Randomized clinical study of the efficacy of amiloride and potassium canrenoate in nonazotemic cirrhotic patients with ascites
1994
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding
2010 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Cumulative H. pylori Eradication Rates in Clinical Practice by Adopting First and Second-Line Regimens Proposed by the Maastricht III Consensus and a Third-Line Empirical Regimen
2008
Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: Results of a prospective controlled trial
1995
Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease
2016
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Tailored versus Triple plus Bismuth or Concomitant Therapy as Initial Helicobacter pylori Treatment: A Randomized Trial
2015
Ascites in Children
2016
Microbial Translocation in Chronic Liver Diseases
2012
Variability in Prevalence ofHelicobacter pyloriStrains Resistant to Clarithromycin and Levofloxacin in Southern Poland
2012
Temporal Relationship Between Hyperaldosteronism, Sodium Retention and Ascites Formation in Rats With Experimental Cirrhosis
1985
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Staphylococcus aureus Bacteremia
2003
Ten day sequential versus 10 day modified bismuth quadruple therapy as empirical firstline and secondline treatment for Helicobacter pylori in Chinese patients: an open label, randomised, crossover trial
2013
Meta-analysis: Duration of First-Line Proton-Pump Inhibitor–Based Triple Therapy for Helicobacter pylori Eradication
2007
Acute Effects of Captopril on Systemic and Renal Hemodynamics and on Renal Function in Cirrhotic Patients With Ascites
1985
Spontaneous bacterial peritonitis in cirrhosis: Predictive factors of infection resolution and survival in patients treated with cefotaxime
1993
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Meta-Analysis of Sequential, Concomitant and Hybrid Therapy for <i>Helicobacter pylori</i> Eradication
2015
Systemic Antibiotic Therapy Prevents Bacterial Infection in Cirrhotic Patients With Gastrointestinal Hemorrhage
1994
Antibiotic Prophylaxis for the Prevention of Bacterial Infections in Cirrhotic Patients With Gastrointestinal Bleeding: A Meta–Analysis
1999
Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade “A” Success Rate for First-LineHelicobacter pyloriEradication
2015
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Clinical Evaluation of a Ten‐Day Regimen with E someprazole, M etronidazole, A moxicillin, and C larithromycin for the Eradication of H elicobacter pylori in a High Clarithromycin Resistance Area
2013
Optimised empiric triple and concomitant therapy forHelicobacter pylorieradication in clinical practice: the OPTRICON study
2015
Effects of therapeutic paracentesis on systemic and hepatic hemodynamics and on renal and hormonal function
1987
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
First-line eradication rates comparing two shortened non-bismuth quadruple regimens againstHelicobacter pylori: an open-label, randomized, multicentre clinical trial
2015
Portal Hypertension and Its Complications
2008
A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients
1991
Sequential, concomitant and hybrid first-line therapies for Helicobacter pylori eradication: a prospective randomized study
2014
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications
2012
Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites
1997
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
Myocarditis Related to Drug Hypersensitivity
1985
Spontaneous bacterial peritonis
1985
Antibiotic prophylaxis in cirrhosis: Good and bad
2015
In Vivo Neutrophil Dysfunction in Cirrhotic Patients with Advanced Liver Disease
2000
Cefotaxime Is More Effective Than Is Ampicillin–Tobramycin in Cirrhotics With Severe Infections
1985
Compensated cirrhosis: Natural history and prognostic factors
1987
Concomitant and hybrid therapy for H elicobacter pylori infection: A randomized clinical trial
2015
Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial
1998
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Antimicrobial Susceptibility‐Guided Therapy Versus Empirical Concomitant Therapy for Eradication of Helicobacter pylori in a Region with High Rate of Clarithromycin Resistance
2015
Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy
2015
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
SPONTANEOUS BACTERIAL PERITONITIS
1992
Sequential or concomitant therapy for eradication of H elicobacter pylori infection: A systematic review and meta‐analysis
2015
Works of Felipe Bory being referenced
Comparison of Paracentesis and Diuretics in the Treatment of Cirrhotics With Tense Ascites
1987
Hemodynamic changes in patients developing effective hypovolemia after total paracentesis
1998
Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice
2013
Applicability of the Rockall score in patients undergoing endoscopic therapy for upper gastrointestinal bleeding
2005
One‐week triple vs. quadruple therapy for Helicobacter pylori infection — a randomized trial
2002
Seven versus Ten Days of Rabeprazole Triple Therapy for Helicobacter pylori Eradication: A Multicenter Randomized Trial
2005
Daily Norfloxacin Is More Effective Than Weekly Rufloxacin in Prevention of Spontaneous Bacterial Peritonitis Recurrence
2002
Comparison of Two Management Strategies for Helicobacter pylori Treatment: Clinical Study and Cost‐effectiveness Analysis
2005
Accuracy of GastroPanel for the diagnosis of atrophic gastritis
2014
Second-line Therapy With Levofloxacin After Failure of Treatment to Eradicate Helicobacter pylori Infection
2012
Long-Term Follow-Up of 1,000 Patients Cured of Helicobacter pylori Infection Following an Episode of Peptic Ulcer Bleeding
2012
Third-Line Rescue Therapy with Levofloxacin After Two H. pylori Treatment Failures
2006
Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites
1983
Oral, Nonabsorbable Antibiotics Prevent Infection in Cirrhotics With Gastrointestinal Hemorrhage
1985
High‐dose, ten‐day esomeprazole, amoxicillin and metronidazole triple therapy achieves high H elicobacter pylori eradication rates
2012
Reticuloendothelial System Phagocytic Activity in Cirrhosis and Its Relation to Bacterial Infections and Prognosis†
1984
PARACENTESIS VERSUS DIURETICS IN THE TREATMENT OF CIRRHOTICS WITH TENSE ASCITES
1985
Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites
1987